Date published: 2026-5-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

INTS8 Inhibitors

INTS8 inhibitors are chemical compounds that selectively target the INTS8 protein, a subunit of the Integrator complex. This complex is a large, multi-protein assembly involved in the regulation of gene expression, particularly through the processing and termination of small nuclear RNAs (snRNAs) and the modulation of transcription from RNA polymerase II. INTS8 plays a structural and regulatory role within the Integrator complex, and inhibitors of INTS8 are designed to interfere with these functions, disrupting the complex's ability to process RNA effectively. Such inhibition can lead to alterations in transcriptional regulation, splicing events, and other post-transcriptional modifications essential for the correct expression and maturation of RNA molecules.

These inhibitors typically function by binding to INTS8 directly or by affecting its interaction with other subunits of the Integrator complex. This interference can impede the structural integrity of the complex, leading to downstream effects on cellular RNA handling and gene expression. INTS8 inhibitors are often studied to explore the molecular mechanisms of RNA processing, transcription regulation, and to understand how the Integrator complex modulates different gene expression pathways. Since the Integrator complex is crucial for maintaining proper cellular function, chemical compounds targeting INTS8 provide valuable insights into the roles that this protein and its associated complex play in both normal cellular physiology and broader biological processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Inhibits RNA Polymerase II (Pol II), potentially affecting snRNA processing and integrator complex activity.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

Impacts transcription elongation by Pol II, potentially influencing integrator complex functions.

Flavopiridol Hydrochloride

131740-09-5sc-207687
10 mg
$317.00
(2)

Cyclin-dependent kinase inhibitor, affecting transcription regulation, possibly impacting INTS8.

RGFP966

1357389-11-7sc-507300
5 mg
$115.00
(0)

Selective inhibitor of histone deacetylase 3 (HDAC3), could indirectly affect transcription and INTS8 activity.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

HDAC inhibitor, potentially influencing chromatin structure and impacting integrator complex activity.

Panobinostat

404950-80-7sc-208148
10 mg
$200.00
9
(1)

Broad HDAC inhibitor, may affect chromatin structure and transcription, indirectly impacting INTS8.

CPI-203

1446144-04-2sc-501599
1 mg
$170.00
(0)

Inhibits CREB binding protein (CBP)/p300, could influence transcription regulation and INTS8 function.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

Inhibits BET bromodomain proteins, potentially affecting transcription and thus INTS8 activity.

THZ1

1604810-83-4sc-507542
1 mg
$95.00
(0)

CDK7 inhibitor, affecting transcription initiation and elongation, may impact INTS8.

Pladienolide B

445493-23-2sc-391691
sc-391691B
sc-391691A
sc-391691C
sc-391691D
sc-391691E
0.5 mg
10 mg
20 mg
50 mg
100 mg
5 mg
$299.00
$5699.00
$11099.00
$25500.00
$66300.00
$2875.00
63
(2)

Inhibits the spliceosome, potentially affecting processes relevant to INTS8.